Skip to main content
OpenTrials

Clinical trial condition

Ovarian Cancer

Explore clinical trials studying Ovarian Cancer. Study availability and eligibility vary by location and protocol.

1,442 public trials 325 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Cancer trial results

Recruiting

Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer

NCT04918186

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • BCCA - Kelowna Kelowna, British Columbia, Canada
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • Odette Cancer Centre Toronto, Ontario, Canada
View Trial Details
Recruiting

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

NCT04751435

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +38 more
Locations
  • Kings County Hopsital Center Brooklyn, New York, United States
  • Queens Cancer Center of Queens Hospital Jamaica, New York, United States
  • Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities) New York, United States
  • Jamaica Hospital Medical Center (Data Collection Only) Richmond Hill, New York, United States
View Trial Details
Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

NCT07023627

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Usa Health Mitchell Cancer Institute Mobile, Alabama, United States
  • University of California, Los Angeles Medical Center Los Angeles, California, United States
  • Scripps Healthscripps Mercy Hospital Prebys Cancer Center San Diego, California, United States
  • Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 74 locations
View Trial Details
Recruiting

Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer

NCT07564141

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Danbury Hospital Danbury, Connecticut, United States
  • ProHealth Care Inc Waukesha, Wisconsin, United States
View Trial Details
Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

NCT06293898

Conditions
Adnexal Diseases, Biliary Tract Cancer, Biliary Tract Diseases, +51 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Cedars Sinai Los Angeles, California, United States
  • Scripps Health San Diego, California, United States
View all 17 locations
View Trial Details
Recruiting

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

NCT07546500

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Site 0107 Phoenix, Arizona, United States
  • Site 0110 Antioch, California, United States
  • Site 0115 San Francisco, California, United States
  • Site 0101 Torrance, California, United States
View all 58 locations
View Trial Details

Related conditions